| Company | Designation | Period |
|---|---|---|
| FAU Erlangen-Nürnberg | Postdoctoral Researcher | May 2022 – Jan 2023 |
| FAU Erlangen-Nürnberg | Doctoral Student | Jul 2018 – May 2022 |
| Aurigene Oncology Limited | Scientist 2 | Jan 2023 – May 2023 |
| Aurigene Oncology Limited | Scientist 3, Aurigene Oncology; PhD in Cell Biology, Universitätsklinikum Erlangen; Founder | May 2023 – Present |
| PhDs of India | Founder | May 2020 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Aurigene Oncology Limited corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Payel Das's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Aurigene Oncology Limited's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)